Gradalis® Presents Initial Data from Phase II U.S. Trial for Ewing’s sarcoma at the Annual Meeting of the Children’s Oncology Group

World News: . []

DALLAS Nov 09 2018 GLOBE NEWSWIRE -- LINK  Inc a clinical-stage immunotherapy company developing investigational treatments for individuals suffering from LINK  cancer indications presented LINK  data from its Phase 2 trial for Ew ing’s...

More news and information about Gradalis, Inc.

Published By:

Globe Newswire: 15:04 GMT Friday 9th November 2018

Published: .

Search for other references to "gradalis" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us